The antitumor activity of anti-HER2 scFv–HSA–DM1 conjugates, T-SA1–DM1 and T-SA2–DM1, was evaluated in HER2-positive human ovarian cancer xenograft models. The gene discussed is ALB; the disease is ovarian carcinoma.